ShareHope Medicine Co., Ltd. (TPEX:8403)
Taiwan
· Delayed Price · Currency is TWD 27.00
+0.05 (0.19%)
Aug 15, 2025, 1:30 PM CST
ShareHope Medicine Revenue
ShareHope Medicine had revenue of 1.07B TWD in the quarter ending June 30, 2025, a decrease of -1.74%. This brings the company's revenue in the last twelve months to 4.39B, up 6.97% year-over-year. In the year 2024, ShareHope Medicine had annual revenue of 4.33B with 11.68% growth.
Revenue (ttm)
4.39B
Revenue Growth
+6.97%
P/S Ratio
0.81
Revenue / Employee
37.17M
Employees
118
Market Cap
3.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.33B | 452.45M | 11.68% |
| Dec 31, 2023 | 3.87B | -263.75M | -6.38% |
| Dec 31, 2022 | 4.14B | 287.10M | 7.46% |
| Dec 31, 2021 | 3.85B | -248.85M | -6.07% |
| Dec 31, 2020 | 4.10B | 974.99M | 31.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Lumosa Therapeutics | 37.25M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |